» Articles » PMID: 19076776

PI3K Signaling in Glioma--animal Models and Therapeutic Challenges

Overview
Journal Brain Pathol
Date 2008 Dec 17
PMID 19076776
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

The PI3 kinase (PI3K) family plays a complex role in cell biology and metabolism. Signaling through the PI3Ks is frequently activated in many human cancers, including glioblastoma, because of gain-of-function mutations in PIK3CA or loss of PTEN. Experiments involving genetic mouse models and small molecule inhibitors have helped to elucidate the roles of the regulatory and catalytic subunits of PI3K in metabolism and cancer. Downstream of PI3K is Akt, a critical effector of growth, proliferation and survival. The suggested dependence of glioblastoma tumors on PI3K signaling implies that PI3K inhibitors should lead to effective killing of these cancer cells, but that has been shown not to be the case. The engagement of other survival pathways in response to PI3K inhibition prompts the need to develop combination therapies that promote cytotoxicity in cancer cells.

Citing Articles

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities.

Zhang J, Zhang J, Yang C J Transl Med. 2025; 23(1):52.

PMID: 39806481 PMC: 11727735. DOI: 10.1186/s12967-024-06063-0.


Exploring glioma heterogeneity through omics networks: from gene network discovery to causal insights and patient stratification.

Kastendiek N, Coletti R, Gross T, Lopes M BioData Min. 2024; 17(1):56.

PMID: 39696678 PMC: 11657291. DOI: 10.1186/s13040-024-00411-y.


Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas.

Grimi A, Bono B, Lazzarin S, Marcheselli S, Pessina F, Riva M Int J Mol Sci. 2024; 25(16).

PMID: 39201639 PMC: 11354416. DOI: 10.3390/ijms25168953.


Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance.

Hwang Y, Lee D, Lee E, Oh J Cells. 2024; 13(16.

PMID: 39195222 PMC: 11353125. DOI: 10.3390/cells13161332.


Application of Quercetin and its Novel Formulations in the Treatment of Malignancies of Central Nervous System: An Updated Review of Current Evidence based on Molecular Mechanisms.

Jamshidi-Mouselou M, Hashemi A, Jamshidi-Mouselou M, Farkhondeh T, Pourhanifeh M, Samarghandian S Curr Med Chem. 2024; 31(26):4180-4198.

PMID: 38265392 DOI: 10.2174/0109298673266672231121173432.


References
1.
Shaw R, Cantley L . Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006; 441(7092):424-30. DOI: 10.1038/nature04869. View

2.
Hippert M, OToole P, Thorburn A . Autophagy in cancer: good, bad, or both?. Cancer Res. 2006; 66(19):9349-51. DOI: 10.1158/0008-5472.CAN-06-1597. View

3.
Grahame Hardie D . Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology. 2003; 144(12):5179-83. DOI: 10.1210/en.2003-0982. View

4.
Yu J, Zhang Y, McIlroy J, Orr G, Backer J . Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol. 1998; 18(3):1379-87. PMC: 108851. DOI: 10.1128/MCB.18.3.1379. View

5.
Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C . Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal. 2008; 1(36):ra3. PMC: 2694958. DOI: 10.1126/scisignal.1161577. View